Corticosteroid-resistant acute exacerbation of rheumatoid arthritis-associated interstitial lung disease in a patient on maintenance hemodialysis: a case report
Takahiro Kawasaki* Jun Fukui Hachiro Konaka Jun Fujimoto Kumiko Kobayashi Hiroshi Fujiwara
Division of Rheumatology, Osaka General Medical Center
*Present address: Department of Respiratory Medicine,
Allergy and Rheumatic Disease, Graduate School of Medicine, Osaka University
We report the case of a 47-year-old woman with an acute exacerbation of rheumatoid arthritis-associated interstitial lung disease (RA-ILD) on maintenance hemodialysis (HD). She did not respond to high-dose glucocorticoids, but her condition improved significantly after the administration of cyclosporine A (CsA) and intravenous cyclophosphamide therapy (IVCY). This study reports the case of a patient with RA-ILD on maintenance HD successfully treated with combination therapy using high-dose glucocorticoids, IVCY, and CsA.
Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) Hemodialysis (HD) Cyclophosphamide Cyclosporine A (CsA)
Received 8 May 2018 / Accepted 16 Oct 2018
AJRS, 8(1): 62-66, 2019